Healthcare provider profile · identity verified

Jennifer Lo

Family Practice · MOUNT PLEASANT, WI · NPI 1538458401

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	675	168
Levothyroxine Sodium	Levothyroxine Sodium	527	112
Amlodipine Besylate	Amlodipine Besylate	427	115
Losartan Potassium	Losartan Potassium	389	99
Simvastatin	Simvastatin	388	103
Lisinopril	Lisinopril	333	75
Metformin Hcl Er	Metformin Hcl	261	62
Sertraline Hcl	Sertraline Hcl	241	54
Furosemide	Furosemide	227	64
Omeprazole	Omeprazole	225	65
Metoprolol Succinate	Metoprolol Succinate	213	58
Gabapentin	Gabapentin	212	52
Pantoprazole Sodium	Pantoprazole Sodium	207	56
Hydrochlorothiazide	Hydrochlorothiazide	203	51
Albuterol Sulfate Hfa	Albuterol Sulfate	192	81
Rosuvastatin Calcium	Rosuvastatin Calcium	165	46
Alendronate Sodium	Alendronate Sodium	134	36
Lorazepam	Lorazepam	128	23
Trazodone Hcl	Trazodone Hcl	125	32
Metoprolol Tartrate	Metoprolol Tartrate	114	27
Potassium Chloride	Potassium Chloride	113	31
Metformin Hcl	Metformin Hcl	109	34
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	108	20
Tizanidine Hcl	Tizanidine Hcl	103	37
Tramadol Hcl	Tramadol Hcl	102	24
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	98	27
Fluticasone Propionate	Fluticasone Propionate	97	35
Alprazolam	Alprazolam	96	24
Fluoxetine Hcl	Fluoxetine Hcl	95	15
Glipizide Er	Glipizide	90	21
Pravastatin Sodium	Pravastatin Sodium	89	21
Duloxetine Hcl	Duloxetine Hcl	81	18
Meloxicam	Meloxicam	81	26
Citalopram Hbr	Citalopram Hydrobromide	78	16
Bupropion Xl	Bupropion Hcl	74	17
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	74	20
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	72	18
Clopidogrel	Clopidogrel Bisulfate	69	14
Montelukast Sodium	Montelukast Sodium	69	16
Escitalopram Oxalate	Escitalopram Oxalate	68	16
Triamcinolone Acetonide	Triamcinolone Acetonide	65	21
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	63	18
Methylprednisolone	Methylprednisolone	63	58
Hydralazine Hcl	Hydralazine Hcl	62	14
Tamsulosin Hcl	Tamsulosin Hcl	61	15
Zolpidem Tartrate	Zolpidem Tartrate	60	16
Paroxetine Hcl	Paroxetine Hcl	56	11
Venlafaxine Hcl Er	Venlafaxine Hcl	55	14
Eliquis	Apixaban	54	11
Carvedilol	Carvedilol	53	13
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	53	17
Allopurinol	Allopurinol	51	17
Atenolol	Atenolol	49	suppressed
Celecoxib	Celecoxib	49	15
Jardiance	Empagliflozin	46	12
Ezetimibe	Ezetimibe	44	11
Oxybutynin Chloride Er	Oxybutynin Chloride	41	suppressed
Clonidine Hcl	Clonidine Hcl	39	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	39	16
Quetiapine Fumarate	Quetiapine Fumarate	39	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	38	25
Famotidine	Famotidine	37	suppressed
Ropinirole Hcl	Ropinirole Hcl	34	suppressed
Nystatin	Nystatin	33	11
Synthroid	Levothyroxine Sodium	33	suppressed
Warfarin Sodium	Warfarin Sodium	33	suppressed
Meclizine Hcl	Meclizine Hcl	32	14
Mounjaro	Tirzepatide	32	suppressed
Spironolactone	Spironolactone	31	suppressed
Valsartan	Valsartan	30	suppressed
Buspirone Hcl	Buspirone Hcl	29	suppressed
Lovastatin	Lovastatin	29	suppressed
Mirtazapine	Mirtazapine	29	suppressed
Naproxen	Naproxen	29	11
Rybelsus	Semaglutide	29	suppressed
Trulicity	Dulaglutide	29	suppressed
Xarelto	Rivaroxaban	29	suppressed
Azithromycin	Azithromycin	28	25
Ozempic	Semaglutide	28	suppressed
Breo Ellipta	Fluticasone/Vilanterol	26	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	26	24
Symbicort	Budesonide/Formoterol Fumarate	26	suppressed
Tradjenta	Linagliptin	24	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	23	21
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	23	suppressed
Diclofenac Sodium	Diclofenac Sodium	22	suppressed
Enalapril Maleate	Enalapril Maleate	22	suppressed
Ibuprofen	Ibuprofen	22	suppressed
Topiramate	Topiramate	22	suppressed
Azelastine Hcl	Azelastine Hcl	21	suppressed
Dexlansoprazole Dr	Dexlansoprazole	21	suppressed
Januvia	Sitagliptin Phosphate	21	suppressed
Fluconazole	Fluconazole	20	15
Myrbetriq	Mirabegron	20	suppressed
Pregabalin	Pregabalin	20	suppressed
Valacyclovir	Valacyclovir Hcl	20	suppressed
Clonazepam	Clonazepam	19	suppressed
Donepezil Hcl	Donepezil Hcl	19	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	18	suppressed
Diazepam	Diazepam	18	12
Glimepiride	Glimepiride	18	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	18	suppressed
Ondansetron Odt	Ondansetron	18	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	18	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	17	16
Oxybutynin Chloride	Oxybutynin Chloride	17	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	17	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	16	suppressed
Fenofibrate	Fenofibrate,micronized	16	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	16	suppressed
Spiriva Handihaler	Tiotropium Bromide	16	suppressed
Gemfibrozil	Gemfibrozil	15	suppressed
Levetiracetam	Levetiracetam	15	suppressed
Prednisone	Prednisone	15	14
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	14	suppressed
Estradiol	Estradiol	14	suppressed
Folic Acid	Folic Acid	14	suppressed
Ipratropium Bromide	Ipratropium Bromide	14	suppressed
Lidocaine	Lidocaine	14	suppressed
Nebivolol Hcl	Nebivolol Hcl	14	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	14	suppressed
Torsemide	Torsemide	14	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	13	suppressed
Humalog Kwikpen U-100	Insulin Lispro	13	suppressed
Ibandronate Sodium	Ibandronate Sodium	13	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	13	suppressed
Novolog Flexpen	Insulin Aspart	13	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	13	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	13	suppressed
Ventolin Hfa	Albuterol Sulfate	13	suppressed
Amoxicillin	Amoxicillin	12	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	12	11
Azelastine-Fluticasone	Azelastine/Fluticasone	12	suppressed
Baclofen	Baclofen	12	suppressed
Bupropion Hcl Sr	Bupropion Hcl	12	suppressed
Eszopiclone	Eszopiclone	12	suppressed
Hydrocortisone	Hydrocortisone	12	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	12	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	12	suppressed
Rizatriptan	Rizatriptan Benzoate	12	suppressed
Sucralfate	Sucralfate	12	suppressed
Verapamil Er	Verapamil Hcl	12	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	11	suppressed
Farxiga	Dapagliflozin Propanediol	11	suppressed
Naratriptan Hcl	Naratriptan Hcl	11	suppressed
Temazepam	Temazepam	11	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	11	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error